Action and Reaction

[anonymous]

WIth recent earnings results and market cap of $13B from $40+B, this company needs to go down. That have rotten management Chairman, CEO, President, CIO. They abuse their emploayees. All those who have left or LETGO non-voluntarily are better off. They DO NOT have strategic alternatives. They cannot sell or be bought out (STITCHING). RJC, HB and RM have filled their pockets and will bring this company down. Do not invest! Do not Work there! Hopefully some indictment will come regarding the price fixing scheme. Shame on you Mylan management.

 

[AR60M]

60 Minutes is researching a story about generic drug price increases and allegations that prices went up due to price fixing. We are looking to speak confidentially with sales and marketing representatives in the generic drug industry with any knowledge of this. You can reach Ali Rawaf by email at Rawafa@cbsnews.com, or on encrypted apps Signal and WhatsApp at (347) 756-2548.

 

[anonymous]

Why don’t you just look on linked in? You’ll find all of the former high level folks that worked at Mylan. Just assume they were fired and will be willing to tell you everything you want to know. They won’t hear about this on here. It will be hard to find any former mylan employees who were high level personnel that were not fired. The reason is that they brought a lot of people in from other companies who were legitimate high level executives who worked their way through the ranks of companies - unlike the high level people at mylan who are from West Virginia. Those West Virginia people have jobs for life and are trusted inner circle. They have been promoted to roles that they could never achieve in real world pharmaceutical industry. The people brought in from outside actually tried to get stuff done but were unaware that mylan was not trying to gain additional business. Only trying to split up the market among themselves and their competitors. Eventually they all had to go once they realized that the goal was not to win or gain business.

60 Minutes is researching a story about generic drug price increases and allegations that prices went up due to price fixing. We are looking to speak confidentially with sales and marketing representatives in the generic drug industry with any knowledge of this. You can reach Ali Rawaf by email at Rawafa@cbsnews.com, or on encrypted apps Signal and WhatsApp at (347) 756-2548.

 

[anonymous]

And it all came true. A real shame but the only winners are those who created this mess.